FDA Approves Zurampic for Patients With GoutFDA Approves Zurampic for Patients With Gout

Zurampic (lesinurad) is approved to treat hyperuricemia associated with gout in combination with a xanthine oxidase inhibitor. FDA Approvals
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology News Alert Source Type: news
More News: Gout | Rheumatology